PUBLIC HEALTH:
Reassessing HIV Prevention
Malcolm Potts,1* Daniel T. Halperin,2*† Douglas Kirby,3 Ann Swidler,4 Elliot Marseille,5 Jeffrey D. Klausner,6 Norman Hearst,7 Richard G. Wamai,2 James G. Kahn,5 Julia Walsh1
The largest investments in AIDS prevention targeted to the general population are being made in interventions where the evidence for large-scale impact is uncertain.
1School of Public Health, University of California at Berkeley, Berkeley, CA 94720, USA.
2Harvard University School of Public Health, Boston, MA 02115, USA.
3ETR Associates, Scotts Valley, CA 95066, USA.
4Department of Sociology, University of California at Berkeley, Berkeley, CA 94720, USA.
5Philip R. Lee Institute for Health Policy Studies, University of California at San Francisco, San Francisco, CA 94143, USA.
6San Francisco Department of Public Health, San Francisco, CA 94103, USA.
7Department of Family and Community Medicine, University of California at San Francisco, San Francisco, CA 94143, USA.
*These authors contributed equally to this work.
†Author for correspondence. E-mail: daniel_halperin{at}harvard.edu